Table 3.
Serum uric acid OR (95% CI) | Hyperuricemia OR (95% CI) | |
---|---|---|
Metabolic syndrome (IDF criteria) | 1.342 (1.102–2.305)* | 2.136 (1.525–2.993)* |
Metabolic syndrome component | ||
Abdominal Obesity | 1.320 (1.151–2.412)* | 1.833 (1.204–2.792)* |
High blood pressure | 1.120 (0.898–1.503) | 0.953 (0.615–1.477) |
Hypertriglyceridemia | 1.303 (1.122–2.205)* | 1.843 (1.301–2.612)* |
Low HDL cholesterol | 1.352 (1.182–2.967)* | 1.974 (1.292–3.017)* |
Hyperglycemia | 1.242 (1.156–1.881)* | 1.330 (0.931–1.901) |
Metabolic syndrome (Chinese guideline) | 1.215 (1.109–2.304)* | 1.769 (1.249–2.503)* |
Metabolic syndrome component | ||
Abdominal Obesity | 1.306 (1.138–2.326)* | 1.550 (1.052–2.284)* |
High blood pressure | 1.120 (0.898–1.503) | 0.953 (0.615–1.477) |
Hypertriglyceridemia | 1.303 (1.122–2.205)* | 1.843 (1.301–2.612)* |
Low HDL cholesterol | 1.121 (0.797–1.304) | 1.706 (0.566–2.046) |
Hyperglycemia | 1.102 (0.898–1.602) | 1.114 (0.754–1.647) |
Adjusted for sex, body mass index, low-density lipoprotein, eGFR, cigarette smoking, total cholesterol, low-density lipoprotein, alcohol consumption and medications for hypertension, diabetes mellitus, and hyperlipidemia. eGFR: estimated glomerular filtration rate. HDL: high-density lipoprotein, IDF: international diabetes federation. *p < 0.05.